Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue...
Quest Diagnostics Inc. (DGX) has a valuation score of 70/100 (moderate), profitability score of 49/100 (weak), financial health score of 67/100 (moderate), Piotroski F-Score of 7/9, Altman Z-Score of 2.89 (grey zone), revenue growth of +3.7% YoY.
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 3, 2026
Analyst Recommendations23 analysts · 2026-09-01
6
7
10
Strong Buy 6Buy 7Hold 10Sell 0Strong Sell 0
Recent Market Moves
See all DGX moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 1 | Pre-market | $236.07 | -1.76% | -2.58 |
| Sep 1 | Regular | $236.43 | -1.61% | -2.39 |
| Sep 1 | After-hours | $236.22 | -1.70% | -2.50 |